David S. Utterberg

The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA.

Fresenius Medical Care Holdings, Inc. provides kidney dialysis services and renal care products. It offers specialty pharmacy and laboratory services as well as manufacturing and distributing dialysis equipment, disposable products, and renal pharmaceuticals. The company was founded in 1996 and is headquartered in Waltham, MA.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

DFINE, Inc.engages in the development and commercialization of medical device system for treating vertebral compression fractures. The company was founded by John H. Shadduck and Csaba Truckai in 2004 and is headquartered in South Jordan, UT.

Auxillium Energy, Inc. is an exploration stage company. It engages in the investigation, acquisition, exploration and development of oil and gas properties in Alaska. The company was founded on November 9, 2009 and is headquartered in White Plains, NY.

Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA.

Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ.

Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA.

Arteaus Therapeutics LLC develops therapies for migraine prevention. The company was founded by Dave Grayzel and Scott C. Chappel on July 15, 2011 and is headquartered in Cambridge, MA.

Healthcare Systems & Technologies LLC engages in the provision of cloud-based software solutions for ambulatory surgery centers. It offers HSTpathways, HSTeChart, HSTanesthesia, and HSTSchedule Sharing. The company was founded Tom Hui in 2005 and is headquartered in Lafayette, CA.

Vasca, Inc. develops access and related technologies. It manufactures and markets life site hemodialysis access system technologies to improve the quality of patient care in the United States. The company was founded by Jeffrey H. Burbank in April 1996 and is headquartered in Tewksbury, MA.

Blue Cross & Blue Shield of Arizona, Inc. engages in the provision of health insurance products and services. It offers various health plans for individuals, families, and small and large businesses. The company was founded in 1939 and is headquartered in Phoenix, AZ.

WebPT, Inc. engages in the development of rehab therapy platform for enhancing patient care. Its solutions include practice management, interoperability, onboarding, and clinical supplies. The company was founded by Brad Jannenga and Heidi Jannenga in 2006 and is headquartered in Phoenix, AZ.

Advances In Kidney Disease & Health provides awareness on kidney and urinary tract diseases. The organization helps to increase the availability of all organs for transplantation. The company was founded in 1950 and is headquartered in New York, NY.

Gambro, Inc. provides medical technology and healthcare services. It offers renal care services, products and blood component technology. The company develops and supplies hemodialysis, peritoneal and acute dialysis products. Gambro was founded by Kevin M. Smith in 1968 and is headquartered in Lakewood, CO.

Part of Fresenius Medical Care AG & Co. KGaA, NxStage Medical UK Ltd. was founded in 2011 and is based in Amersham, UK. NxStage offers 24/7 Technical Support and Home Haemodialysis Training and Support to help patients and clinicians feel more comfortable while treating at home. The flexibility of the System One allows patients to play an active role in their health. NxStage aims to provide patients with the information they need to help them better cope with chronic kidney disease (CKD) and improve their quality of life.

Part of Fresenius Medical Care AG, NxStage GmbH & Co. KG is a German company that manufactures medical apparatus and materials. The company is based in Goettingen, Germany. The CEOs of the company are Hendrik Klukkert, Jeffrey H. Burbank.

MedVentive, Inc. provides healthcare and medical technology solutions for healthcare delivery networks, payers and employer coalitions. It offers medical cost containment and healthcare quality improvement solutions. MedVentive architects its solutions to deliver sophisticated data management systems and resources to leading provider organizations. The firm combining clinical data from multiple sources, MedVentive calculates clinical measures accurately, manages patient interventions efficiently, and impacts your bottom line directly. The company was founded by Jonathan M. Niloff in 1997 and is headquartered in Waltham, MA.

LRVHealth LP invests in companies located in the United States. The fund targets companies operating in the fields of healthcare IT, tech enabled healthcare services, medical devices, and diagnostics. It provides financing for seed and early-stage transactions. It also makes follow-on investments.

Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada.

Emphasys Medical, Inc., a medical technology company, focuses on developing and commercializing minimally invasive therapeutic devices for the treatment of patients with emphysema and other breathing disorders. It offers Zephyr Endobronchial Valve system, which is designed to block air from passing through the opening in the lung and into the chest cavity, resulting in the reduction or elimination of airflow through the leak to allow the tissue to heal. The company offers its products through distributors and dealers in Europe, Australia, Hong Kong, and Singapore. Emphasys Medical was founded in 2000 and is based in Redwood City, CA. Emphasys Medical, Inc. operates as a subsidiary of Pulmonx Corp.